2010
DOI: 10.1016/j.jnutbio.2009.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
26
1
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 28 publications
(31 citation statements)
references
References 57 publications
2
26
1
2
Order By: Relevance
“…It has also been shown that intact dietary soy protein, but not an ISF-rich soy extract improved plasma lipids in ovariectomized cynomolgus monkeys (Greaves et al 1999). Additionally, 20 % SPI significantly reduced abdominal fat, liver TG and accumulation of lipid droplets in SD rats compared to 20 % casein diet containing the similar amount of genistein to the SPI diet (Simmen et al 2010). Our results are also supported by a study showing hypolipidemic effects of bconglycinin, one of the major soy storage proteins, in the hypercholesterolemic rats, which are comparable to the hypolipidemic drugs, fenofibrate and rosuvastatin (Ferreira et al 2012).…”
Section: Discussionmentioning
confidence: 96%
See 2 more Smart Citations
“…It has also been shown that intact dietary soy protein, but not an ISF-rich soy extract improved plasma lipids in ovariectomized cynomolgus monkeys (Greaves et al 1999). Additionally, 20 % SPI significantly reduced abdominal fat, liver TG and accumulation of lipid droplets in SD rats compared to 20 % casein diet containing the similar amount of genistein to the SPI diet (Simmen et al 2010). Our results are also supported by a study showing hypolipidemic effects of bconglycinin, one of the major soy storage proteins, in the hypercholesterolemic rats, which are comparable to the hypolipidemic drugs, fenofibrate and rosuvastatin (Ferreira et al 2012).…”
Section: Discussionmentioning
confidence: 96%
“…Feeding soy diets attenuated the formation and accumulation of liver lipid droplets and reduced TG content in both obese (Tovar et al 2005;Gudbrandsen et al 2006;Davis et al 2007) and non-obese rats (Simmen et al 2010). However, the molecular events involved in the hypolipidemic effects and NAFLD prevention of soy are different in obese and non-obese animals.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Це відставання (на 14-15 %) спостерігалося й у 6-місячних щурів. Така затримка соматичного розвитку, можливо, викликана здатністю ФЕ гальмува-ти синтез білка [13], змінювати експресію генів білків у печінці, які регулюють мета-болізм жирних кислот і тиреоїдних гормонів [14]. Крім того, у тварин обох груп статеве дозрівання за часом опущення яєчок запіз-нювалося порівняно зі щурами контрольної групи: 24,0±0,3 щодо 22,6±0,4 доби (Р<0,01).…”
Section: результати та їх обговоренняunclassified
“…The consumption of soy protein may also lead to low hepatic deposits of triglycerides (Ascencio et al, 2004), reducing the risk of hepatic lipotoxicity and therefore of steatosis (Tovar et al, 2005). In animals, soybean protein modulated the expression of genes that regulated lipid metabolism and thyroid hormone, promoting weight loss (Simmen et al, 2010). These mechanisms of action may attenuate metabolic changes that occur in obesity, which are related to insulin resistance (Oh et al, 2011).…”
Section: Effects On Obesity and Metabolic Syndromementioning
confidence: 99%